陈广通

编辑:系统管理员 | 阅读: 次 | 发布时间:2012-11-04

陈广通 :男, 1981 2 月生,副教授,硕士研究生导师,江苏省 "333 高层次人才 " 优秀青年学术骨干培养对象,国家青年科学基金获得者。 2003 7 月沈阳药科大学中药学专业本科毕业,获理学学士学位; 2008 7 月沈阳药科大学天然药物化学专业博士研究生毕业,获理学博士学位。现为南通大学药学院药学系副主任、药学实验中心副主任、中国药学会会员。主要从事天然活性成分的生物转化和中药药效物质基础研究,近五年主持国家及市厅级研究课题 3 项,获得授权发明专利2项。
近五年第一作者或通讯作者代表作:
1. Two novel hydroperoxylated products of 20(S)-protopanaxadiol produced by Mucor racemosus and their cytotoxic activities against human prostate cancer cells. Biotechnology Letters, 35: 439-443, 2013.
2. Microbial transformation of 20(S)-protopanaxatriol by Absidia corymbifera and their cytotoxic activities against two human prostate cancer cell lines. Biotechnology Letters, 35: 91-95, 2013.
3. Microbial transformation of 20(S)-protopanaxadiol by Absidia corymbifera. Cytotoxic activity of the metabolites against human prostate cancer cells. Fitoterapia, 84: 6-10, 2013.
4. Biotransformation of 20(S)-protopanaxadiol by Aspergillus niger AS 3.1858. Fitoterapia, 91: 256-260, 2013.
5. Biotransformation of 20(S)-protopanaxatriol by Aspergillus niger and the cytotoxicity of the resulting metabolites. Phytochemistry Letters , 11: 111-115, 2015.
6. Microbial transformation of 20(S)-protopanaxatriol by Mucor spinosus. Biotechnology Letters , 37(2): 397-402, 2015.
7. Acetylcholinesterase inhibitory dimeric indole derivatives from the marine actinomycetes Rubrobacter radiotolerans. Fitoterapia , 102: 203-207, 2015.
8. Biotransformation of 20(S)-protopanaxatriol by Mucor racemosus and the anti-cancer activities of some products. Biotechnology Letters , 37: 2005-2009, 2015.